Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Columbia University patents SERT/VMAT2 inhibitors

Feb. 17, 2022

NTS-104 reduces critical neuroinflammatory signaling in rat embolic stroke model

Feb. 16, 2022

Alamar and SciNeuro to discover and develop novel therapeutic antibodies for neurological diseases

Feb. 16, 2022

Aquinnah and Roche collaborate in ALS and neurodegenerative diseases

Feb. 16, 2022

Vasopressin V1A receptor antagonists discovered at Roche

Feb. 16, 2022

Therapeutics Solutions reports preclinical data on CampbellCell stem cell therapy for schizophrenia

Feb. 15, 2022

Cofilin siRNA, a promising therapy for treatment of hemorrhagic stroke

Feb. 15, 2022

New complement C1s subcomponent inhibitors discovered at Annexon

Feb. 15, 2022

STC-2 administration confers post-stroke functional recovery in a preclinical model

Feb. 14, 2022

Targeting sphingolipid synthesis has multiple beneficial effects in Duchenne model

Feb. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...